These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39105529)

  • 1. Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for Serbia.
    Burgess C; Lisul B; Pawaskar M; Petigara T; Murtagh J; Kanazir M; Loncarevic G; Carias C
    Pediatr Infect Dis J; 2024 Oct; 43(10):1011-1017. PubMed ID: 39105529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
    Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.
    Ma C; Li F; Zheng X; Zhang H; Duan M; Yang Y; Hao L; Su Q; Rodewald L; Guo B; Xiao S; Wang H; Li L; Li J; Luo H; Gao L
    BMC Infect Dis; 2015 Jan; 15():23. PubMed ID: 25608672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries.
    Packham A; Taylor AE; Karangwa MP; Sherry E; Muvunyi C; Green CA
    Int J Public Health; 2024; 69():1606997. PubMed ID: 38725903
    [No Abstract]   [Full Text] [Related]  

  • 7. Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study.
    Tang XY; Cheng M; Geater A; Deng QY; Zhong G; Lin YD; Chen N; Lan T; Jiang LY; Zhu MT; Li Q
    Infect Dis Poverty; 2021 Jul; 10(1):102. PubMed ID: 34294157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
    Hu Y; Chen Y; Wang Y; Liang H
    Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive study of measles vaccination second dose reporting and barriers to improving coverage in six districts in Malawi.
    Chirwa G; Wilkins KA; Mercer DJ
    Pan Afr Med J; 2020; 35(Suppl 1):5. PubMed ID: 32373256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
    Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
    Elife; 2021 Jun; 10():. PubMed ID: 34165077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timeliness vaccination of measles containing vaccine and barriers to vaccination among migrant children in East China.
    Hu Y; Li Q; Luo S; Lou L; Qi X; Xie S
    PLoS One; 2013; 8(8):e73264. PubMed ID: 24013709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
    Manandhar P; Wannemuehler K; Danovaro-Holliday MC; Nic Lochlainn L; Shendale S; Sodha SV
    Vaccine; 2023 Jan; 41(1):61-67. PubMed ID: 36396512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
    BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis.
    Nic Lochlainn LM; de Gier B; van der Maas N; van Binnendijk R; Strebel PM; Goodman T; de Melker HE; Moss WJ; Hahné SJM
    Lancet Infect Dis; 2019 Nov; 19(11):1246-1254. PubMed ID: 31548081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timeliness and completeness of measles vaccination among children in rural areas of Guangxi, China: A stratified three-stage cluster survey.
    Tang X; Geater A; McNeil E; Zhou H; Deng Q; Dong A
    J Epidemiol; 2017 Jul; 27(7):317-324. PubMed ID: 28187960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India.
    Panda BK; Mishra S; Awofeso N
    BMC Public Health; 2020 Aug; 20(1):1221. PubMed ID: 32778085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.
    Kostandova N; Loisate S; Winter A; Moss WJ; Giles JR; Metcalf CJE; Mutembo S; Wesolowski A
    Epidemics; 2022 Dec; 41():100647. PubMed ID: 36343498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards elimination of measles in Kenya, 2003-2016.
    Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
    Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.